CNS Drugs
Last updated ISSN 1172-7047
CNS Drugs is published by Adis, Springer Healthcare in medicine. It is a subscription journal. The article processing charge is $5,090.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close CNS Drugs is — and show you journals like it.
What it publishes
Recent work in CNS Drugs concentrates on these topics, taken from its published record rather than from its own description:
- Schizophrenia research and treatment
- Epilepsy research and treatment
- Treatment of Major Depression
- Pharmacological Effects and Toxicity Studies
- Bipolar Disorder and Treatment
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Parkinson's Disease Mechanisms and Treatments
- Attention Deficit Hyperactivity Disorder
- Multiple Sclerosis Research Studies
Key facts
| Publisher | Adis, Springer Healthcare |
|---|---|
| ISSN | 1172-7047, 1179-1934 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | $5,090 |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 2,955 |
| Publishing since | 1952 |
| Journal website | www.springer.com/journal/40263 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like CNS Drugs
Other established journals in medicine, if this one is not the right home for your paper:

